41:57duration 41 minutes 57 seconds
Tony Hunter enters the archives to share 50 years…
Tony Hunter enters the archives to share 50 years of Salk stories and cancer discoveries
Tony Hunter, PhD, is a cancer biologist,…
01:09:35duration 1 hour 9 minutes
Ron Evans - Cancer Course
UCSD Cancer Course
44:34duration 44 minutes 34 seconds
Tony Hunter - Perspectives on the science that…
Tony Hunter - Perspectives on the science that Salk has enabled me to do over the past 50 years and where it has led
Tony Hunter 50th Symposium
33:14duration 33 minutes 14 seconds
John Brognard - Tracking down the elusive dark…
John Brognard - Tracking down the elusive dark kinome to identify new cancer drug targets
42:16duration 42 minutes 16 seconds
Susan Taylor - How elucidating the structure of…
Susan Taylor - How elucidating the structure of the protein kinase A catalytic domain has enabled the development of selective kinase inhibitors
39:05duration 39 minutes 5 seconds
Lew Cantley - The discovery of PI-3 kinase and…
Lew Cantley - The discovery of PI-3 kinase and how tyrosine phosphorylation leads to PI-3 kinase signaling, and the development of PI-3 kinase inhibitors as cancer drugs
32:44duration 32 minutes 44 seconds
Sara Courtneidge - From the discovery that SRC is…
Sara Courtneidge - From the discovery that SRC is a membrane protein to its role in cell invasion through activating invadosome function
20:16duration 20 minutes 16 seconds
American Cancer Society Professor Tony Hunter -…
American Cancer Society Professor Tony Hunter - Podcast Season 1
Tony Hunter is an American Cancer Society…
17:53duration 17 minutes 53 seconds
Tony Hunter -It took you five years to start…
Tony Hunter -It took you five years to start working on RTKs after arriving at Salk in 1985 – the rest is history